Keep all your medications clearly labeled and accompany them with a doctors letter or prescription or both, to be safe
Guests with new, severe, persistent, or unexplained symptoms
Products offered by Purity Peptides are intended exclusively for laboratory research, analytical testing, and scientific investigation.These materials are not intended for human or veterinary use, consumption, administration, diagnosis, treatment, mitigation, cure, or prevention of any disease or medical condition.By purchasing from Purity Peptides, the purchaser acknowledges that all products are being acquired solely for lawful research purposes and will be handled in accordance with applicable regulations and accepted laboratory practices.The purchaser assumes responsibility for the proper handling, storage, and use of all materials
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
The FDA subsequently classified AOD-9604 within Category 2 of the bulk drug substance review process, and the compound was later withdrawn from that nomination in April 2026
